September 17th 2025
The Phase IIa trial will further explore the EP4 antagonist HTL0039732 in combination with immunotherapy to improve outcomes in resistant solid tumors and expand treatment options.
September 16th 2025
September 15th 2025
High-Cell-Density Culture to Produce Plasmid DNA for Gene Therapy in E. coli
How to produce Plasmid DNA in a high-cell-density culture.
Purification Strategies to Process 5 g/L Titers of Monoclonal Antibodies
Altering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.
The Development and Application of a Monoclonal Antibody Purification Platform
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.